GlassScriptPhysician profile
Daniel A Linarello
NPI 1518950286
$2,214.67
in general payments reported to CMS, 2019-2025
19 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $749 · 2020: $208 · 2021: $14.63 · 2022: $173 · 2023: $479 · 2024: $343 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $646.45 | 2019-2020 | |
| Kerecis Limited | $467.77 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medtronic USA, INC. | $310.26 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $219.86 | 2023-2025 | |
| Sientra, INC. | $173.00 | 2022 | |
| Hartmann USA, INC. | $65.00 | 2023 | Zetuvit Plus |
| Hologic INC | $50.00 | 2024 | Localizer |
| Pacira Pharmaceuticals Incorporated | $46.81 | 2023-2025 | Exparel, Iovera |
| Smith+Nephew, INC. | $32.47 | 2024-2025 | Collagenase Santyl, Renasys Touch, Pico 14 |
| Tela Bio, INC. | $32.15 | 2024 | Ovitex 2s |
| Vertex Pharmaceuticals Incorporated | $31.16 | 2024-2025 | |
| Veracyte, INC. | $23.47 | 2023 | |
| Abbvie INC. | $22.10 | 2024 | |
| Davol INC. | $19.84 | 2025 | Phasix Mesh |
| Kci USA, INC. | $18.59 | 2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.63 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $13.81 | 2023 | Caldolor |
| Reprise Biomedical, INC. | $13.78 | 2024 | Miro3d |
| Becton, Dickinson and Company | $13.52 | 2023 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Linarello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.